Dr. Agnès Ducoulombier

Short Bio

Career path

• To be completed

Education

• To be completed

Publications

• Rodrigues M, Servois V, Mariani P, Pracht M, Dutriaux C, Grillet F, Ryckwaert T, Ducoulombier A, Neidhardt EM, Piperno-Neumann S. Management of metastatic uveal melanoma: French expert consensus guidelines. Bull Cancer. Published online July 7, 2025:S0007-4551(25)00274-7. doi: 10.1016/j.bulcan.2025.05.011
• Piperno-Neumann S, Koning L de, Marchal T, Gastaud L, Waechter L, Fogliarini A, Bouleuc C, Libert Y, Seban R, Thery L, Ducoulombier A, Rodrigues M, Bredart A, Savignoni A, Dolbeault S, Burnod A. Early palliative care in metastatic uveal melanoma (early together): protocol of a prospective randomized Phase III trial. Melanoma Manag. 2024;11(1):2382080. doi: 10.1080/20450885.2024.2382080
• Mosele F, Deluche E, Lusque A, Le Bescond L, Filleron T, Pradat Y, Ducoulombier A, Pistilli B, Bachelot T, Viret F, Levy C, Signolle N, Alfaro A, Tran DTN, Garberis IJ, Talbot H, Christodoulidis S, Vakalopoulou M, Droin N, Stourm A, Kobayashi M, Kakegawa T, Lacroix L, Saulnier P, Job B, Deloger M, Jimenez M, Mahier C, Baris V, Laplante P, Kannouche P, Marty V, Lacroix-Triki M, Diéras V, André F. Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial. Nat Med. 2023;29(8):2110-2120. doi: 10.1038/s41591-023-02478-2
• Zaibet S, Hautefeuille V, Auclin E, Lièvre A, Tougeron D, Sarabi M, Gilabert M, Wasselin J, Edeline J, Artru P, Bechade D, Morin C, Ducoulombier A, Taieb J, Pernot S. Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study. Br J Cancer. 2022;126(10):1394-1400. doi: 10.1038/s41416-022-01713-w
• Croce S, Ducoulombier A, Ribeiro A, Lesluyes T, Noel JC, Amant F, Guillou L, Stoeckle E, Devouassoux-Shisheboran M, Penel N, Floquet A, Arnould L, Guyon F, Mishellany F, Chakiba C, Cuppens T, Zikan M, Leroux A, Frouin E, Farre I, Genestie C, Valo I, MacGrogan G, Chibon F. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors. Mod Pathol. 2018;31(5):816-828. doi: 10.1038/modpathol.2017.185